Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Mol Genet Metab. 2016 Jul 25;119(1-2):68–74. doi: 10.1016/j.ymgme.2016.07.007

Table 2.

Lab findings of twenty five patients with SUCLG1 mutations

SCS activity ETC activity mtDNA copy# Respiration
analysis
SUCLG1 levels by
WB
SUCLG2
levels by
WB
SUCLA2
levels by
WB
P1 NA Abnormal in mu 15% of controls(mu) NA Abscent(fb) NA NA
P2 NA Abnormal in Liver 15% of controls in Liver NA Abscent(fb) NA NA
P3 NA NA NA NA NA NA NA
P4 NA Very mildly reduced Decreased(mu) by southern blot Mildly reduced Severely reduced(fb) NA NA
P5 NA Reduced(mu) 7–10% of controls(mu) NA NA NA NA
P6 NA Reduced(mu) 7–10% of controls(mu) NA NA NA NA
P7 NA Reduced (mu & fb) 11% of controls(mu) NA Abscent(fb) NA Abscent(fb)
P8 NA Reduced (mu & fb) 18% of controls(mu) NA Reduced(fb) NA Reduced(fb)
P9 NA Reduced(mu) 48% of controls(mu) Reduced(mu) NA NA NA
P10 NA Reduced(mu) 25% of controls(mu) Reduced(mu) NA NA NA
P11 NA NA 128% of controls(mu) NA NA NA NA
P12 Deficient NA 50% of controls in Liver NA Severely reduced NA NA
P13 NA severe C IV and II+III deficiencies 18% of controls(mu) NA NA NA NA
P14 NA Reduced(fb & mu) No change (fb) & doubled (mu) NA NA NA NA
P15 NA NA NA NA NA NA NA
P16 NA Severely reduced(mu) 27% of controls(mu) NA NA NA NA
P17 NA Reduced CV (leu) 90% of controls(leu) NA NA NA NA
P18 NA Reduced CI (leu) 75% of controls(leu) NA NA NA NA
P19 NA Reduced CI (leu) 68% of controls(leu) NA NA NA NA
P20 NA Normal NA NA NA NA NA
P21 NA Mildly reduced CI &CIV NA NA NA NA NA
P22 NA NA NA NA NA NA NA
P23 NA Severely reduced CI &CIV NA NA NA NA NA
P24 NA Normal NA NA NA NA NA
P25 Severly reduced NA 72% of control(mu) & 50% of
control (fb)
Reduced(fb) Absent(fb) Abscent(fb) Reduced(fb)

Abbreviations are as follows: NA, not available; SCS, succinylcoA-synthetase; ETC, electron transport chain; mu, muscle; fb, fibroblasts; leu, leukocytes